Solesence, Inc. Common Stock (SLSN) - Total Assets
Based on the latest financial reports, Solesence, Inc. Common Stock (SLSN) holds total assets worth $53.99 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SLSN total equity for net asset value and shareholders' equity analysis.
Solesence, Inc. Common Stock - Total Assets Trend (2021–2024)
This chart illustrates how Solesence, Inc. Common Stock's total assets have evolved over time, based on quarterly financial data.
Solesence, Inc. Common Stock - Asset Composition Analysis
Current Asset Composition (December 2024)
Solesence, Inc. Common Stock's total assets of $53.99 Million consist of 58.7% current assets and 41.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.8% |
| Accounts Receivable | $4.87 Million | 9.7% |
| Inventory | $20.27 Million | 40.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2021–2024)
This chart illustrates how Solesence, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Solesence, Inc. Common Stock (SLSN) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Solesence, Inc. Common Stock's current assets represent 58.7% of total assets in 2024, an increase from 40.9% in 2021.
- Cash Position: Cash and equivalents constituted 2.8% of total assets in 2024, up from 2.3% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is inventory at 40.5% of total assets.
Solesence, Inc. Common Stock Competitors by Total Assets
Key competitors of Solesence, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Colgate Palmolive (India) Limited
NSE:COLPAL
|
India | Rs30.19 Billion |
|
Hangzhou Haoyue Personal Care Co Ltd
SHG:605009
|
China | CN¥5.22 Billion |
|
Perfect Group Corp Ltd Class A
SHG:603059
|
China | CN¥2.24 Billion |
|
Profit Cultural & Creative Group Co Ltd
SHE:300640
|
China | CN¥1.12 Billion |
|
Coreana Cosmetics Co.Ltd
KQ:027050
|
Korea | ₩105.60 Billion |
|
Mcphersons Ltd
AU:MCP
|
Australia | AU$117.21 Million |
|
Fujian Green Pine Co Ltd
SHE:300132
|
China | CN¥2.23 Billion |
|
European Wax Center Inc
NASDAQ:EWCZ
|
USA | $720.70 Million |
Solesence, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.84 | 1.28 | 1.05 |
| Quick Ratio | 0.78 | 0.63 | 0.40 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $14.93 Million | $6.47 Million | $713.00K |
Solesence, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Solesence, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.53 |
| Latest Market Cap to Assets Ratio | 1.88 |
| Asset Growth Rate (YoY) | 52.1% |
| Total Assets | $50.00 Million |
| Market Capitalization | $93.81 Million USD |
Valuation Analysis
Above Book Valuation: The market values Solesence, Inc. Common Stock's assets above their book value (1.88x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Solesence, Inc. Common Stock's assets grew by 52.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Solesence, Inc. Common Stock (2021–2024)
The table below shows the annual total assets of Solesence, Inc. Common Stock from 2021 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $50.00 Million | +52.07% |
| 2023-12-31 | $32.88 Million | -2.02% |
| 2022-12-31 | $33.56 Million | +18.19% |
| 2021-12-31 | $28.39 Million | -- |
About Solesence, Inc. Common Stock
Solesence, Inc., a science-driven company, develops, manufactures, and sells integrated family of technologies in the United States. The company engages in engineered materials, formulation development, and commercial manufacturing. It also provides skin care formulations with mineral-based UV protection enabled by proprietary active pharmaceutical ingredients under the Solésence brand; skin heal… Read more